Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Inhalte:

  • => Welche Forschungsthemen werden an der Medizinischen Universität bearbeitet?.
  • => Wer ist daran beteiligt und welche Methoden werden angewandt?.
  • => Welche Fördergeber unterstützen welche Projekte?.
  • => Wo werden Forschungsergebnisse publiziert?.

Facts and Figures: 2.363 Forscher*innenprofile (davon 847 mit ORCID-ID), 6.858 Forschungsprojekte, 137.123 Publikationen, Posters und Vorträge, 54.206 Volltextlinks (davon Volltext frei zugänglich: > 23.154 (Open Access) )

Aktuelle Zitierungen im Web of Science: 1.474.050, davon 2.913 citation classics (>=100 Zitierungen) Summe Altmetrics Score: 198.639

Aktuell durch Fördergeber bewilligte Forschungsprojekte:

PHYSIK-BASIERTE MASCHINEN-LERNEN BASIERTE PRÄDIKTION UND RÜCKBILDUNG VON GESTÖRTER NÜCHTERNGLUKOSE
Projektleitung: Mader Julia
Laufzeit: 01.01.2023 - 31.12.2025
Geldgeber: Europäische Kommission

Vascular Health in Aging and Disease
Projektleitung: Rainer Peter
Laufzeit: 01.11.2022 - 31.10.2027
Geldgeber: Medizinische Universität Graz

> Weitere neue Projekte

Die aktuellsten Publikationen in "Top-Journalen" (Top 20 % Impact Ranking):


25.11.2022:

Montali, C; Abbruzzetti, S; Franzen, A; Casini, G; Bruno, S; Delcanale, P; Burgstaller, S; Ramadani-Muja, J; Malli, R; Gensch, T; Viappiani, C Nitric Oxide Sensing by a Blue Fluorescent Protein.
Antioxidants (Basel). 2022; 11(11): Doi: 10.3390/antiox11112229
PubMed FullText FullText_MUG

 

21.11.2022:

Desoye, G; Ringholm, L; Damm, P; Mathiesen, ER; van Poppel, MNM Secular trend for increasing birthweight in offspring of pregnant women with type 1 diabetes: is improved placentation the reason?
DIABETOLOGIA. 2022; Doi: 10.1007/s00125-022-05820-4
Web of Science PubMed FullText FullText_MUG

 

21.11.2022:

De Leon, G; Frohlich, E; Fink, E; Di Pizio, A; Salar-Behzadi, S Premexotac: Machine learning bitterants predictor for advancing pharmaceutical development
INT J PHARMACEUT. 2022; 628: 122263 Doi: 10.1016/j.ijpharm.2022.122263
Web of Science PubMed FullText FullText_MUG

 

21.11.2022:

Campo, E; Jaffe, ES; Cook, JR; Quintanilla-Martinez, L; Swerdlow, SH; Anderson, KC; Brousset, P; Cerroni, L; de Leval, L; Dirnhofer, S; Dogan, A; Feldman, AL; Fend, F; Friedberg, JW; Gaulard, P; Ghia, P; Horwitz, SM; King, RL; Salles, G; San-Miguel, J; Seymour, JF; Treon, SP; Vose, JM; Zucca, E; Advani, R; Ansell, S; Au, WY; Barrionuevo, C; Bergsagel, L; Chan, WC; Cohen, JI; d'Amore, F; Davies, A; Falini, B; Ghobrial, IM; Goodlad, JR; Gribben, JG; Hsi, ED; Kahl, BS; Kim, WS; Kumar, S; LaCasce, AS; Laurent, C; Lenz, G; Leonard, JP; Link, MP; Lopez-Guillermo, A; Mateos, MV; Macintyre, E; Melnick, AM; Morschhauser, F; Nakamura, S; Narbaitz, M; Pavlovsky, A; Pileri, SA; Piris, M; Pro, B; Rajkumar, V; Rosen, ST; Sander, B; Sehn, L; Shipp, MA; Smith, SM; Staudt, LM; Thieblemont, C; Tousseyn, T; Wilson, WH; Yoshino, T; Zinzani, PL; Dreyling, M; Scott, DW; Winter, JN; Zelenetz, A The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
BLOOD. 2022; 140(11): 1229-1253. Doi: 10.1182/blood.2022015851
Web of Science PubMed FullText FullText_MUG

 

21.11.2022:

Meszaros, N; Lind, K; Sehlke, R; Vilagos, B; Krall, N; Vladimer, GI; Sill, H Influence of cryopreservation on drug responses and gene expression of AML cells: Implications for the use of biobanked tissues
BRIT J HAEMATOL. 2022; Doi: 10.1111/bjh.18557
Web of Science PubMed FullText FullText_MUG

 

21.11.2022:

Stander, S; Zeidler, C; Augustin, M; Darsow, U; Kremer, AE; Legat, FJ; Koschmieder, S; Kupfer, J; Mettang, T; Metz, M; Nast, A; Raap, U; Schneider, G; Stander, H; Streit, M; Schut, C; Weisshaar, E S2k guideline: Diagnosis and treatment of chronic pruritus
J DTSCH DERMATOL GES. 2022; 20(10): 1387-1402. Doi: 10.1111/ddg.14830
Web of Science PubMed FullText FullText_MUG

 

21.11.2022:

Krenn, M; Sener, M; Rath, J; Zulehner, G; Keritam, O; Wagner, M; Laccone, F; Iglseder, S; Marte, S; Baumgartner, M; Eisenkolbl, A; Liechtenstein, C; Rudnik, S; Quasthoff, S; Grinzinger, S; Spenger, J; Wortmann, SB; Loscher, WN; Zimprich, F; Kellersmann, A; Rappold, M; Bernert, G; Freilinger, M; Cetin, H The clinical and molecular landscape of congenital myasthenic syndromes in Austria: a nationwide study
J NEUROL. 2022; Doi: 10.1007/s00415-022-11440-0
Web of Science PubMed FullText FullText_MUG

 

21.11.2022:

Michalowitz, AL; Burmann, SN; Oellig, F; Assaf, C; Cerroni, L; Kreuter, A Bendamustine monochemotherapy in aggressive or advanced-stage primary cutaneous T-cell lymphomas
J EUR ACAD DERMATOL. 2022; Doi: 10.1111/jdv.18691
Web of Science PubMed FullText FullText_MUG

 

21.11.2022:

Wirth, AK; Wange, L; Vosberg, S; Henrich, KO; Rausch, C; Özdemir, E; Zeller, CM; Richter, D; Feuchtinger, T; Kaller, M; Hermeking, H; Greif, PA; Senft, D; Jurinovic, V; Bahrami, E; Jayavelu, AK; Westermann, F; Mann, M; Enard, W; Herold, T; Jeremias, I In vivo PDX CRISPR/Cas9 screens reveal mutual therapeutic targets to overcome heterogeneous acquired chemo-resistance.
Leukemia. 2022; Doi: 10.1038/s41375-022-01726-7
Web of Science PubMed FullText FullText_MUG

 

21.11.2022:

Sorger, H; Dey, S; Vieyra-Garcia, PA; Poloske, D; Teufelberger, AR; de Araujo, ED; Sedighi, A; Graf, R; Spiegl, B; Lazzeri, I; Braun, T; Alonso, IGD; Schlederer, M; Timelthaler, G; Kodajova, P; Pirker, C; Surbek, M; Machtinger, M; Graier, T; Perchthaler, I; Pan, Y; Fink-Puches, R; Cerroni, L; Ober, J; Otte, M; Albrecht, JD; Tin, G; Abdeldayem, A; Manaswiyoungkul, P; Olaoye, OO; Metzelder, ML; Orlova, A; Berger, W; Wobser, M; Nicolay, JP; Andre, F; Nguyen, V; Neubauer, HA; Fleck, R; Merkel, O; Herling, M; Heitzer, E; Gunning, PT; Kenner, L; Moriggl, R; Wolf, P Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T-cell lymphoma
EMBO MOL MED. 2022; Doi: 10.15252/emmm.202115200
Web of Science PubMed FullText FullText_MUG

 

21.11.2022:

Frede, N; Rieger, E; Lorenzetti, R; Nieters, A; Venhoff, AC; Hentze, C; von Deimling, M; Bartholomae, N; Thiel, J; Voll, RE; Venhoff, N Respiratory tract infections and risk factors for infection in a cohort of 330 patients with axial spondyloarthritis or psoriatic arthritis
FRONT IMMUNOL. 2022; 13: 1040725 Doi: 10.3389/fimmu.2022.1040725
Web of Science PubMed FullText FullText_MUG

 

21.11.2022:

Lenard, AJ; Mulder, FAA; Madl, T Solvent paramagnetic relaxation enhancement as a versatile method for studying structure and dynamics of biomolecular systems
PROG NUCL MAG RES SP. 2022; 132: 113-139. Doi: 10.1016/j.pnmrs.2022.09.001
Web of Science FullText FullText_MUG

 

21.11.2022:

Niedrist, T; Kriegl, L; Zurl, CJ; Schmidt, F; Perkmann-Nagele, N; Mucher, P; Repl, M; Flieder, I; Radakovics, A; Sieghart, D; Radner, H; Aletaha, D; Binder, CJ; Gully, C; Krause, R; Herrmann, M; Wagner, OF; Perkmann, T; Haslacher, H Preanalytical stability of SARS-CoV-2 anti-nucleocapsid antibodies
CLIN CHEM LAB MED. 2022; Doi: 10.1515/cclm-2022-0875
Web of Science PubMed FullText FullText_MUG

 

21.11.2022:

Krishnan, P; Farhan, S; Schneider, P; Kamran, H; Iida, O; Brodmann, M; Micari, A; Sachar, R; Urasawa, K; Scheinert, D; Ando, K; Tarricone, A; Doros, G; Tepe, G; Yokoi, H; Laird, J; Zeller, T Determinants of Drug-Coated Balloon Failure in Patients Undergoing Femoropopliteal Arterial Intervention
J AM COLL CARDIOL. 2022; 80(13): 1241-1250. Doi: 10.1016/j.jacc.2022.06.043
Web of Science PubMed FullText FullText_MUG

 

> Weitere aktuelle Publikationen in Top-Journals

Distribution of Med Uni Graz affiliated publications by field-normalized Journal Impact Factor (JIFnorm)


Med Uni Graz publications1 were assigned quintiles according to the normalized2 Clarivate’s Journal Impact Factor of the journal at the time of publication.


Proportional Distribution: The color-coded columns show the distribution by JIFnorm-quintiles, while the left vertical axis indicates the proportion relative to the total articles published in a given year. The red line shows the total number of articles published each year (right vertical axis).


JIFnorm: Proportional Distribution


Example 1: Around 40% of the over 500 articles with Med Uni Graz affiliation published in 2019 had a normalized JIF > 0.8 (QU1).
Example 2: The proportion of articles published in journals with a normalized JIF < 0.4 (QU4 and QU5) has remained under 20% since 2010.

Absolute Impact: The sum of the normalized JIFs for all published articles in a given year, color-coded according to the respective quintile.


JIFnorm: Absolut Impact


1 This analysis considered only publications categorized as full papers/original articles.

2 IFnorm = (number of journals in WoS category - ranking of journal + 1) / number of journals in WoS category. An IFnorm of 0.8 means that 20% of the journals in this subject category have a higher IF than the respective journal. The highest possible IFnorm is 1, which means that this journal currently has the highest IF in this subject category.

© Med Uni Graz Impressum